Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-06-05T15:54:34.563Z Has data issue: false hasContentIssue false
  • English
  • Français

Delirium and severe illness: Etiologies, severity of delirium and phenomenological differences

Published online by Cambridge University Press:  05 September 2014

Soenke Boettger ,
Josef Jenewein  and
William Breitbart
Soenke Boettger*
Affiliation:
Department of Psychiatry and Psychotherapy, University Hospital Zurich, Zurich, Switzerland
Josef Jenewein
Affiliation:
Department of Psychiatry and Psychotherapy, University Hospital Zurich, Zurich, Switzerland
William Breitbart
Affiliation:
Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York
*
Address correspondence and reprint requests to: Soenke Boettger, University Hospital Zurich, Ramistrasse 100, CH-8091 Zurich, Switzerland. E-Mail: soenke.boettger@usz.ch
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Our aim was to examine the characteristics of delirium in the severely medically ill cancer population on the basis of sociodemographic and medical variables, delirium severity, and phenomenology, as well as severity of medical illness.

Method:

All subjects in the database were recruited from psychiatric referrals at Memorial Sloan Kettering Cancer Center (MSKCC). Sociodemographic and medical variables, as well as the Karnofsky Performance Status (KPS) scale and Memorial Delirium Assessment Scale (MDAS) scores were recorded at baseline. Subsequently, these variables were analyzed with respect to the severity of the medical illness.

Results:

Out of 111 patients, 67 qualified as severely medically ill. KPS scores were 19.7 and 30.7 in less severe illness. There were no significant differences with respect to age, history of dementia, and MDAS scores. Although the severity of delirium did not differ, an increased frequency and severity of consciousness disturbance, disorientation, and inability to maintain and shift attention did exist. With respect to etiologies contributing to delirium, hypoxia and infection were commonly associated with severe illness. In contrast, corticosteroid administration was more often associated with less severe illness. There were no differences with respect to opiate administration, dehydration, and CNS disease, including brain metastasis.

Significance of Results:

Delirium in the severely medically ill cancer population has been characterized by an increased disturbance of consciousness, disorientation, and an inability to maintain and shift attention. However, the severity of illness did not predict severity of delirium. Furthermore, hypoxia and infection were etiologies more commonly associated with delirium in severe illness, whereas the administration of corticosteroids was associated with less severe illness.

Keywords

DeliriumSeverity of medical illnessPhenomenologyEtiologies
Type
Original Articles
Information
Palliative & Supportive Care , Volume 13 , Issue 4 , August 2015 , pp. 1087 - 1092
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, 4th ed., Text Revision (DSM–IV–TR). Washington, DC: American Psychiatric Association (see esp. pp. 124–127).Google Scholar
Bond, S.M., Neelon, V.J. & Belyea, M.J. (2006). Delirium in hospitalized older patients with cancer. Oncology Nursing Forum, 33, 1075–1083.CrossRefGoogle ScholarPubMed
Breitbart, W. & Strout, D. (2000). Delirium in the terminally ill. Clinics in Geriatric Medicine, 16, 357–372.Google Scholar
Breitbart, W., Rosenfeld, B., Roth, A., et al. (1997). The Memorial Delirium Assessment Scale. Journal of Pain and Symptom Management, 13, 128–137.CrossRefGoogle ScholarPubMed
Bucht, G., Gustafson, Y. & Sandberg, O. (1999). Epidemiology of delirium. Dementia and Geriatric Cognitive Disorders, 10, 315–318.Google Scholar
Centeno, C., Sanz, A. & Bruera, E. (2004). Delirium in advanced cancer patients. Palliative Medicine, 18, 184–194.CrossRefGoogle ScholarPubMed
Fann, J.R., Alfano, C.M., Burington, B.E., et al. (2005). Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantation. Cancer, 103, 810–820.CrossRefGoogle ScholarPubMed
Francis, J., Martin, D. & Kapoor, W.N. (1990). A prospective study of delirium in hospitalized elderly. The Journal of the American Medical Association, 263, 1097–1101.Google Scholar
Gagnon, P., Allard, P., Masse, B., et al. (2000). Delirium in terminal cancer: A prospective study using daily screening, early diagnosis, and continuous monitoring. Journal of Pain and Symptom Management, 19, 412–426.CrossRefGoogle Scholar
Gaudreau, J.D., Gagnon, P., Harel, F., et al. (2005). Psychoactive medications and risk of delirium in hospitalized cancer patients. Journal of Clinical Oncology, 20(23), 6712–6718.Google Scholar
Inouye, S.K. (1998). Delirium in hospitalized older patients. Clinics in Geriatric Medicine, 14, 745–764.Google Scholar
Karnofsky, D.A. & Burchenal, J.H. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of chemotherapeutic agents. Macleod, C.M. (ed.), pp. 191–205. New York: Columbia University Press.Google Scholar
Lawlor, P.G., Gagnon, B., Mancini, I.L., et al. (2000 a). Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Archives of Internal Medicine, 160, 786–794.Google Scholar
Lawlor, P.G., Nekolaichuk, C., Gagnon, B., et al. (2000 b). Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: Assessing delirium in advanced cancer. Cancer, 88, 2859–2867.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Levkoff, S.E., Liptzin, B., Evans, D.A., et al. (1994). Progression and resolution of delirium in elderly patients hospitalized for acute care. The American Journal of Geriatric Psychiatry, 2, 230–238.CrossRefGoogle ScholarPubMed
Lipowski, Z.J. (1989). Delirium in the elderly patient. The New England Journal of Medicine, 320, 578–582.Google Scholar
Ljubisavljevic, V. & Kelly, B. (2003). Risk factors for development of delirium among oncology patients. General Hospital Psychiatry, 25, 345–352.Google Scholar
Massie, M.J., Holland, J. & Glass, E. (1983). Delirium in terminally ill cancer patients. The American Journal of Psychiatry, 140, 1048–1050.Google Scholar
McCusker, J., Cole, M., Dendukuri, N., et al. (2003). The course of delirium in older medical inpatients: A prospective study. Journal of General Internal Medicine, 18, 696–704.CrossRefGoogle ScholarPubMed
Trzepacz, P.T., Mulsant, B.H., Amanda, D.M., et al. (1998). Is delirium different when it occurs in dementia? A study using the delirium rating scale. The Journal of Neuropsychiatry and Clinical Neurosciences, 10, 199–204.Google Scholar
Trzepacz, P.T., Breitbart, W., Franklin, J., et al. (1999). Practice guidelines for the treatment of patients with delirium of the American Psychiatric Association. The American Journal of Psychiatry, 156, 1–20.Google Scholar
Voyer, P., McCusker, J., Cole, M.G., et al. (2007). Factors associated with delirium severity among older patients. Journal of Clinical Nursing, 16, 819–831.CrossRefGoogle ScholarPubMed